Pharmaniaga Berhad (KLSE:PHARMA)

Pharmaniaga Berhad Cash Flow Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	127.79	-80.16	-629.92	172.15	27.49
Depreciation & Amortization	36.31	38.77	34.02	31.7	30.76
Other Amortization	5.07	2.93	2.41	1.68	1.58
Other Operating Activities	-126.5	85.41	451.15	-269.58	-85.54
Operating Cash Flow	42.67	46.95	-142.34	-64.06	-25.71
Operating Cash Flow Growth	-9.12%	-	-	-	-
Capital Expenditures	-31.16	-50.67	-59.26	-30.39	-9.25
Sale of Property, Plant & Equipment	0.08	1.32	0.06	0.21	0
Sale (Purchase) of Intangibles	-8.41	-10.34	-18.38	-14.97	-23.38
Other Investing Activities	-	-8.24	5.25	-0.41	-
Investing Cash Flow	-39.49	-67.93	-72.34	-45.56	-32.64
Short-Term Debt Issued	-	50	-	-	-
Long-Term Debt Issued	18.67	3,248	2,291	2,329	1,541
Total Debt Issued	18.67	3,298	2,291	2,329	1,541
Long-Term Debt Repaid	-7.99	-3,240	-1,988	-2,149	-1,443
Total Debt Repaid	-7.99	-3,240	-1,988	-2,149	-1,443
Net Debt Issued (Repaid)	10.67	57.48	303.42	179.73	97.72
Issuance of Common Stock	-	45.86	-	-	-
Common Dividends Paid	-	-7.86	-82.53	-58.95	-26.14
Other Financing Activities	11.43	-0.21	-0.1	-0.04	-0.09
Financing Cash Flow	22.1	95.27	220.79	120.74	71.49
Foreign Exchange Rate Adjustments	-0.52	0.31	-0.39	0.13	-0.23
Net Cash Flow	24.76	74.59	5.74	11.25	12.91
Free Cash Flow	11.51	-3.72	-201.6	-94.44	-34.96
Free Cash Flow Margin	0.31%	-0.11%	-5.79%	-1.96%	-1.28%
Free Cash Flow Per Share	0.01	-0.00	-0.15	-0.07	-0.03
Cash Interest Paid	68.11	60.81	41.29	32.63	38.57
Cash Income Tax Paid	33.89	20.56	39.52	39.7	2.94
Levered Free Cash Flow	0.83	31.75	479.12	-143.76	-75.73
Unlevered Free Cash Flow	45.81	70.4	504.15	-122.93	-54.67
Change in Net Working Capital	119.08	-102.48	-525.76	304.8	97.56

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.